Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

NCT06995508 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Cancer-Associated Anorexia
Head and Neck Squamous Cell Carcinoma
Neck Squamous Cell Carcinoma of Unknown Primary

Interventions

OTHER: Best Practice
DRUG: Olanzapine
OTHER: Questionnaire Administration

Sponsor

Roswell Park Cancer Institute